hVIVO (LON:HVO) Shares Down 6.8% – What’s Next?

hVIVO plc (LON:HVO) shares fell 6.8% on Friday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).

hVIVO Price Performance

The firm has a 50-day simple moving average of GBX 23.39 and a 200-day simple moving average of GBX 26.71. The firm has a market cap of £129.44 million, a P/E ratio of 634.17 and a beta of 0.97. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.